The UK also drops AstraZeneca: no under 30

A few days after the second promotion with “full marks” Ema admits: “The AstraZeneca vaccine can trigger very rare types of thrombosis”, while the United Kingdom bans it to very young people for the same reason

Till now Boris Johnson he had been the main sponsor of AstraZeneca and the reason is soon said: his government has financed research and development of the Anglo-Swedish product with a veritable torrent of jingling pounds. Till now. Exactly. Because, after having implemented a carpet vaccination that is often taken as an example by the advocates of the absolute safety of that drug, the Tory executive has surprisingly decided to impose some limitations on its administration.

The UK health authority has indeed announced that the AstraZeneca vaccine “will not be administered to patients under the age of 30, due to the rare risk of blood clots.” Persons in the indicated age group will therefore be given the Pfizer vaccine or the Moderna vaccine. A real bolt from the blue that throws dismay and further increases the confusion.

Meanwhile, the European Medicines Agency also had to retrace its steps and, a few days after the second promotion with flying colors, admit the existence of possible serious collateral damage. “The AstraZeneca vaccine can trigger very rare types of thrombosis,” the EMA wrote yesterday in a note, at the end of the planned re-evaluation following the adverse events that affected people who had received the Anglo-Swedish vaccine. The European medicines agency therefore asks to “include rare thrombosis among the AstraZeneca vaccine side effects”, while reaffirming that “the benefits of the vaccine outweigh the risks”. Following the Agency’s new stance, Belgium has decided that the AstraZeneca vaccine will no longer be given to people under 56.

April 8, 2021April 7, 2021

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.